Effectiveness of Departmental Education on Reducing 5% Albumin Administration


  • Study type

  • Study IDs

  • Describes the nature of a clinical study. Types include:

    • Observational study — observes people and measures outcomes without affecting results.
    • Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
    • Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
  • Site IRB
    • Rochester, Minnesota: 16-000059
    Sponsor Protocol Number: 16-000059

About this study

The goal of this study is to better understand why anesthesia providers utilize albumin within the operative setting, to the area of clinical specialty, years of service, and position within the anesthesia department. With the knowledge obtained, department wide education will be developed and offered to all anesthesia providers imparting appropriate uses of albumin, based on the current research. 

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. If you need assistance understanding the eligibility criteria, please contact the study team.

See eligibility criteria

Inclusion Criteria: 

  • All anesthesia providers, [Anesthesiologists (MDAs), Certified Registered Nurse Anesthetists (CRNAs), Anesthesia Fellows, Anesthesia Residents, Student Registered Nurse Anesthetists (SRNAs)] at Mayo Clinic Rochester
  • All patients who have undergone general anesthesia, regional anesthesia, or monitored anesthesia care for surgeries and procedures in the operative suites, performed at Mayo Clinic Rochester, over the specified 6-month periods of time will make up the subjects for our data-mart retrieval. 

Exclusion Criteria: 

  • There are no exclusion criteria for the anesthesia providers who will be asked to participate in the survey. 
  • Patient data to be excluded includes those receiving albumin anywhere outside of the operative suites/procedural area setting, at Mayo Clinic Rochester and outside of the specified dates. 

Participating Mayo Clinic locations

Study statuses change often. Please contact us for help.

Mayo Clinic Location Status

Rochester, Minn.

Mayo Clinic principal investigator

Adam Jacob, M.D.

Closed for enrollment


Mayo Clinic Footer